Nasa Rhinathiol (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasa Rhinathiol, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and allergic rhinitis by constricting blood vessels in the nasal mucosa.

GNH USA supplies Nasa Rhinathiol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is used as a nasal decongestant to alleviate swelling of the nasal passages.

Nasal congestion due to common cold: reduces swelling of nasal mucosa and improves airflow. Sinusitis: alleviates nasal blockage and facilitates sinus drainage. Allergic rhinitis: diminishes congestion caused by allergic inflammation.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging - Nasal dryness or irritation - Sneezing - Headache

Serious or Rare Side Effects: - Persistent nasal congestion (rebound congestion) after prolonged use - Nasal ulceration or crusting - Hypertension (rare systemic absorption) - Severe allergic reaction (anaphylaxis)

When using Xylometazoline Hydrochloride, certain precautions should be observed to ensure safe and effective use.

- Duration of use: limit to no more than 3‑5 consecutive days to avoid rebound congestion. - Underlying conditions: avoid in patients with severe hypertension or coronary artery disease without medical advice. - Age restrictions: not recommended for children under 6 years unless directed by a healthcare professional. - Pregnancy and lactation: safety not established; use only if clearly needed and prescribed. - Drug interactions: consult a physician if using monoamine oxidase inhibitors or other vasoconstrictive agents. - Store at room temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Concurrent use of other nasal decongestants (e.g., phenylephrine) may cause excessive vasoconstriction. - MAO inhibitors: risk of hypertensive crisis. - Systemic sympathomimetics (e.g., pseudoephedrine) increase cardiovascular effects.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: may reduce their efficacy. - Beta‑blockers: may mask tachycardia. - Tricyclic antidepressants: monitor for increased blood pressure. - Nasal corticosteroids: generally safe but monitor for local irritation.